tirzepatide weekly Day 3: Mounjaro (Tirzepatide – injection) Class: Dual GLP-1 and GIP receptor agonist Avg Weight Loss: ~20% of baseline weight (SURMOUNT-1 trial) FDA Status: Approved for type 2 diabetes; Fast-tracked for Best day to take tirzepatide:

Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors, distinguishing it from approved medicines such as semaglutide and tirzepatide

That is generally desirable for tissue repair, but could theoretically influence tumor environments

This amplification of endogenous signaling rather than exogenous receptor activation is a mechanistically distinct approach to cognitive enhancement

The lower threshold (BMI 27) reflects that adipose tissue can become pathological even before Class I obesity is reached

Signs You Have Hyperthyroidism Hot flushes, sweating Unintentional weight loss Frequent stools, loose stool or diarrhea Difficulty sleeping and insomnia Anxiety, irritability, or constant fatigue Elevated heart rate Changes in menstrual cycles Reduced libido Bulging eyes Thick red skin on shins or feet Increased appetite Osteoporosis Hand tremors Muscle weakness How is Hyperthyroidism Diagnosed